KLAUSNER ARTHUR J 4
4 · Monopar Therapeutics · Filed Dec 19, 2025
Insider Transaction Report
Form 4
KLAUSNER ARTHUR J
Director
Transactions
- Sale
Common Stock
2025-12-18$67.06/sh−4,660$312,500→ 9,223 total - Sale
Common Stock
2025-12-18$68.09/sh−461$31,389→ 8,762 total
Footnotes (2)
- [F1]The shares were sold in multiple transactions at prices ranging from $67.00 to $67.28, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F2]The shares were sold in multiple transactions at prices ranging from $68.00 to $68.35, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.